Haleon：如果必需品保持稳定，该股票应会表现优异 (NYSE:HLN)
· seekingalpha.com
自2022年从GSK分拆以来，Haleon的表现一直不佳，包括股息在内的年化回报率仅略高于6%。了解为何HLN股票值得买入。
In its four-plus years as an independent company, Haleon ( HLN ) has underperformed. The consumer products giant, spun from GSK ( GSK ) in 2022, has returned a ...